Next Biometrics Group Asa · OSL:NEXT
Next Biometrics Group Asa — Q1 2025 Earnings Presentation
16 slides from Next Biometrics Group Asa's earnings presentation, May 14, 2025
Slide 1: Q1 Presentation
NEXT BIOMETRICS GROUP ASA Q1 Presentation May 14, 2025
Slide 2: Disclaimer
Disclaimer This presentation includes and is based, inter alia, on forward-looking information and statements that are subject to risks and uncertainties that could cause actual results to differ. Such forward-looking information and statements are based on current expectations, estimates and projec
Slide 3: Today's speakers
Today’s speakers Ulf Ritsvall Eirik Underthun CEO, NEXT Biometrics CFO, NEXT Biometrics
Slide 4: Agenda
Agenda 1) Q1 Highlights 2) Q1 Financials 3) Business and market updates 4) Outlook 5) Q&A NEXT BIOMETRICS GROUP ASA
Slide 5: Highlights Q1 2025
Highlights Q1 2025 Improved revenue Pipeline New orders add to the long-term revenue outlook Q1 Revenues at NOK 6.9 million (down 46% compared to Q1 2024) Adjusted Gross Margin of 52% (down from 56% in Q1 2024) Signed new Multi-Year MoU valued at NOK 30 million 6 new design wins First design-win for
Slide 6: Q1 Financials
Q1 Financials
Slide 7: Q1 2025 financial summary
Q1 2025 financial summary Profit and loss Revenues – NOK 6.9 m vs. NOK 12.8 m in Q1 2024 NOK million Q1 2025 Q1 2024 Gross margin – Adjusted Gross margin1) of 52% vs. 56% in Q1 2024 Revenue 6.9 12.8 Operating expenses COGS1) (3.3) (5.6) – Adjusted OPEX of NOK 17.3 m vs. NOK 16.3 m in Q1 2024 Gross p
Slide 8: Business and market updates
Business and market updates
Slide 9: Business updates
Business updates China market recovery still pending – Limited shipments to China this quarter – Resulting in increased priority and greater pursuit of global opportunities in banking, finance, and healthcare – Ongoing collaboration with OEMs for international deployments – Holding for China's uptur
Slide 10: Key Milestone with Major Order from ACPL
Key Milestone with Major Order from ACPL Significant Order Secured • Received NOK 55–107 million order with shipments starting Q2 2025 • Increases confidence in 2H 2025 and 2026 revenue outlook Strengthened Strategic Partnership • Extends collaboration with ACPL reflecting increased demand and marke
Slide 11: FAP30 will be important revenue contributor already in 2025
FAP30 will be important revenue contributor already in 2025 NEXT FAP30 product • Leveraging NEXT Biometrics´ patented NEXT Active Thermal® technology • FAP30 products are more sophisticated than FAP20 and serve different markets / use cases – Not a replacement for FAP20 Opens new market segments • A
Slide 12: Targeting substantial improvements in cash flow
Targeting substantial improvements in cash flow – Improvement in accounts receivable collections during Q1 – Targeting significant growth in cash inflow for Q2 and Q3 – Enhanced credit terms now in place, supporting NEXT’s growth strategy – FAP30 positioned for sales to Western customers meaning sta
Slide 13: Outlook
Outlook
Slide 14: Summary and Outlook
Summary and Outlook Significant Revenue Growth • Expecting revenue of NOK 130 – 160 million for 2025 with even higher upside for 2026 • Majority of 2025 revenue set to be realized in H2 • Expecting Q2/Q3 combined revenue of NOK 60-70 million; slow ramp up Continue to focus on strong FAP20 sales • Un
Slide 15: t's ay
| \ \) | t's ay \ \ / / \ \ / | | | | / 1 aN J “ / mG a)
Slide 16: nextbiometrics.com
nextbiometrics.com
NEXT Biometrics Group — Q1 2025 Earnings Presentation on 6ix